[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fi2a-kEVOyPJwoRhRm9l-gEWgUs4_75rQL0z_D5PJzHs":8,"$f0w_q2xQWgO-bnj2x4UY-xxJyzqFXKicv1aEiBX2FY_c":55,"$fpS5lmvrfSg3qkXNwmWz0y4I_Ma9sEmhRlQ3CTxtproA":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},62444,867178,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","王永超","赵县人民医院","肿瘤科","主治医师",56,0,"聚焦晚期肺癌IV期：综合药品安全用药详解","","https://ystcdn.venuertc.com/venue/AI/ad73e036-3de8-468b-8543-a2cff421481f.jpg","\u003Cdiv class=\"lungcancer_drugguide-content\">\n  \u003Ch1 id=\"material_title\" class=\"lungcancer_drugguide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    聚焦晚期肺癌IV期：综合药品安全用药详解\n  \u003C/h1>\n  \u003Cdiv class=\"lungcancer_drugguide-intro\">\n    我们对“化学药物、免疫制剂、溶剂类药物”在肿瘤综合方案中耳熟能详，不过，临床用药环节存在不少易忽视的关键细节。如何安全地使用静脉化疗药物？免疫治疗时需注意哪些特殊点？每个药品的用法、注意事项、禁忌、储存方法等，实际比想象中复杂。本文以一套典型肺癌IV期治疗方案中的常用药为例，梳理出7个关键用药要点，帮你更安心、更明白地用药。🚦\n  \u003C/div>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg1\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 静脉注射用药：操作要领与时间选择 ⏰\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      静脉注射是IV期肺癌治疗方案（如氯化钠注射液溶媒与化疗、免疫药物）普遍用法。正确操作能保证药效、安全。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>用药时间：\u003C/strong>静脉注射通常必须在医院，由专业护士完成；溶药后须在限定时间内用完，避免变质。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>操作方法：\u003C/strong>药品稀释、混合应严格遵医嘱。部分药物必须在滴注完成前用新溶液配制，不能提前过久。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>正确做法：\u003C/strong>点滴输注速度根据医师开具标准调整；不宜自行调快/慢。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-case\">\n        案例：有位患者在化疗药物输注过程中未经允许擅自加快滴速，结果出现不良反应。正确方式应严格依照护士调控。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 药品剂型与使用细节 🧪\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      治疗方案中常用包括溶液、乳剂、冻干粉等多种剂型。不同剂型的应用有独有要求：\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>溶液：\u003C/strong>氯化钠注射液用作溶媒，需按照化疗或免疫药说明配比；开瓶后数小时内用完，剩余部分必须废弃。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>冻干粉：\u003C/strong>需无菌操作下注入溶剂配制，不能用热水溶解，防止药物降解。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>正确做法：\u003C/strong>每次用药更换输液器械，避免交叉污染。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-tip\">\n        🤔 \u003Cstrong>提醒：\u003C/strong>不同的抗肿瘤药可能外观类似，不可互换；如不清楚应及时询问医护人员。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg3\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 药理机制简析：抗肿瘤药与免疫药 💡\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>细胞毒性药物：\u003C/strong>常见化疗药属于此类，作用于肿瘤细胞的DNA或有丝分裂过程，使癌细胞无法正常增殖。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫治疗药物：\u003C/strong>如部分PD-1、PD-L1抗体，通过解锁免疫系统原本被抑制的杀伤功能，使自身免疫细胞能识别并清除肿瘤细胞。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>氯化钠注射液：\u003C/strong>作为溶剂无直接抗肿瘤作用，主要用于药物稀释或生理支持。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungcancer_drugguide-exp\">\n        \u003Cstrong>数据参考：\u003C/strong>Brahmer等2015年研究指出，免疫检查点抑制剂用于多种实体瘤治疗中可提升生存率（Brahmer, J.R., et al., N Engl J Med, 2015）。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg4\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 用药方法与用量规范 🗂️\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      正确的用药流程是安全与效果的基石。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>剂量：\u003C/strong>化疗和免疫药品一般根据体表面积、体重或专项公式精确计算。在医院由医生依据方案精确调整，不可擅自增减。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>周期：\u003C/strong>化疗/免疫多采用“周期方案”，如每21天一次，每次按标准流程操作。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>使用技巧：\u003C/strong>不应自行分开药品或调整溶液浓度，也避免在家中“维持用量”。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>静脉通道管理：\u003C/strong>建议采用PICC、输液港等安全通道，减少外周静脉刺激。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-case\">\n        案例：一位患者因未使用专用导管连续化疗，静脉刺激严重。正确做法是遵照医嘱安排专业静脉通道，减少局部不适风险。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg5\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 药物相互作用：组合用药的警惕 🚨\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      组合化疗或免疫药物经常需配合其他药品，如降压药、降糖药或其他支持治疗用药。潜在的药物相互作用不可忽视。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>化疗药品：\u003C/strong>部分药品和常用抗凝药、某些抗生素、抗癫痫药有明显相互作用，需调整剂量或避免同时用药。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫类药品：\u003C/strong>应当避免与强免疫抑制剂（如激素）长期合用，以免干扰药效。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>其他组合：\u003C/strong>合并高血压、糖尿病，常需多药联用，推荐所有处方药都报知主治医生。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-exp\">\n        \u003Cstrong>研究提示：\u003C/strong>组合化疗—免疫药与地塞米松等激素联用要严格权衡利弊（Robert, C., et al., Lancet Oncol, 2015）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg6\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 常见不良反应与识别 🩺\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      各类药物都有潜在不良反应。科学识别和及时应对，有助于安全度过治疗期。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>细胞毒性药：\u003C/strong>较多见恶心、口腔黏膜不适、血象下降等，极少数人可能过敏反应。\u003Cspan class=\"lungcancer_drugguide-emoji\">😕\u003C/span>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>免疫药物：\u003C/strong>个别病例可见皮肤、肠道等自身免疫反应，极罕见严重反应。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>氯化钠注射液：\u003C/strong>安全性高，几乎无明显不良反应，但出现静脉渗漏要立即处理。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-tip\">\n        📝 \u003Cstrong>正确做法：\u003C/strong>用药期间出现持续不适、局部肿胀、皮疹等情况，必须第一时间告知医护。\n      \u003C/div>\n      \u003Cdiv class=\"lungcancer_drugguide-exp\">\n        参考数据：美国FDA数据库显示，免疫检查点抑制剂类药品不良反应发生率7%-20%，需密切监控（Topalian et al., N Engl J Med, 2012）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg7\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存、分装与过期处理 🌡️\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>储存温度：\u003C/strong>大部分抗肿瘤药需2-8°C冷链保存，切勿冷冻；溶液如氯化钠注射液密封储藏于阴凉干燥处。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>开封管理：\u003C/strong>药物取出或稀释后须尽快使用，剩余液体不得自行继续保存。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>分装注意：\u003C/strong>禁止将药品私自拆分存放，非专业操作违禁。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期丢弃：\u003C/strong>过期或颜色变化、异味药品必须按有害垃圾处理，不得与生活垃圾混放。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-tip\">\n        🚮 \u003Cstrong>提醒：\u003C/strong>家用冰箱温度波动大，不推荐长期存放处方药。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg8\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 特殊人群注意事项 👴\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      老年、伴肝肾异常或多病共存群体用药必须格外谨慎。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>酌情下调剂量，尤其是肾毒性、骨髓抑制性强的药物。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝肾功能不全患者：\u003C/strong>部分化疗药、免疫药需减少用量或延长间隔，具体由医生根据肝肾检查结果决定。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>多种药物联用：\u003C/strong>需避免自行加药或调药，资讯专科医生，药师定期审查更为靠谱。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"lungcancer_drugguide-exp\">\n        数据来源：Kwak等2020年研究表明，60岁以上患者联合用药发生不良反应的风险上升（Kwak, M., et al., Cancer Chemother Pharmacol, 2020）。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg9\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服、过量与应急处理 🆘\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      虽然大多数抗肿瘤药物在医院静脉用药，产生漏服的概率低，但有些辅助口服药物仍需注意漏服、过量的应急策略。\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>漏服：\u003C/strong>如辅助口服药物漏服一顿，发现后及时补服；若接近下次时间，不双倍服用。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过量：\u003C/strong>静脉注射如出现超量，应立即启动医疗应急处理，口服药物误服超量不能自行催吐，第一时间去医院。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>常规处理原则：\u003C/strong>抗肿瘤药物副作用较重，擅自加量后果严重，不要自行增减剂量或随意服用维生素类“护肝”药。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungcancer_drugguide-exp\">\n        正确做法：所有用药异常，务必医学专业处理，家属不可自行“找办法”。\n      \u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bg10\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">10 总结回顾与安全用药再次提醒 📚\u003C/h2>\n    \u003Cdiv class=\"lungcancer_drugguide-section-content\">\n      \u003Cul>\n        \u003Cli>静脉抗肿瘤和免疫药物需严格依照医院规范由专业人员操作。\u003C/li>\n        \u003Cli>药物配置、使用、保存环节都不能“随意变通”。\u003C/li>\n        \u003Cli>组合药物增加了相互作用风险，主动向医生申报所有药品清单至关重要。\u003C/li>\n        \u003Cli>一旦遇到不良反应、漏服、过量等状况，应当即告知医护，不可自作主张。\u003C/li>\n      \u003C/ul>\n      最后，治疗用药细节关乎疗效与安全，了解每一步规范、及时沟通，是每一位患者与家属要牢记的安全底线。若有疑问，建议随时向肿瘤科医师和药师咨询，做到心中有数、安全用药。🌱\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungcancer_drugguide-section lungcancer_drugguide-ref\">\n    \u003Ch2 class=\"lungcancer_drugguide-section-title lungcancer_drugguide-bgref\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">引用参考文献\u003C/h2>\n    \u003Col>\n      \u003Cli>Brahmer, J. R., et al. (2015). Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 373(2), 123-135.\u003C/li>\n      \u003Cli>Robert, C., et al. (2015). Nivolumab in previously untreated melanoma without BRAF mutation. \u003Cem>Lancet Oncology\u003C/em>, 16(4), 375-384. \u003C/li>\n      \u003Cli>Topalian, S. L., et al. (2012). Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer. \u003Cem>New England Journal of Medicine\u003C/em>, 366(26), 2443-2454.\u003C/li>\n      \u003Cli>Kwak, M., et al. (2020). The Risk of Polypharmacy and Adverse Outcomes in Older Patients Undergoing Chemotherapy. \u003Cem>Cancer Chemotherapy and Pharmacology\u003C/em>, 86(2), 221-229.\u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.lungcancer_drugguide-content {\n  font-family: \"Helvetica Neue\", Arial, \"PingFang SC\", \"Microsoft YaHei\", sans-serif;\n  max-width: 790px;\n  margin: 32px auto 32px auto;\n  background: #fafbfc;\n  border-radius: 10px;\n  box-shadow: 0 4px 18px rgba(38, 60, 90, 0.07);\n  padding: 34px 28px 36px 28px;\n  color: #223047;\n  letter-spacing: 0.02em;\n  line-height: 2.05em;\n  font-size: 17px;\n}\n.lungcancer_drugguide-title {\n  color: #1c384e;\n  font-size: 2.2em;\n  font-weight: 700;\n  text-align: center;\n  margin-bottom: 20px;\n  line-height: 1.4em;\n  letter-spacing: 0.04em;\n  border-bottom: 4px solid #b5d4ec;\n  padding-bottom: 12px;\n  background: linear-gradient(90deg, #e5f1fa 0%, #f7fafb 100%);\n  border-radius: 10px 10px 0 0;\n}\n.lungcancer_drugguide-intro {\n  font-size: 1.14em;\n  color: #284461;\n  margin: 22px 0 30px 0;\n  padding: 15px 20px;\n  background: linear-gradient(100deg, #edfbf9 0%, #f8fafd 80%);\n  border-left: 5px solid #5bc2a7;\n  border-radius: 6px;\n}\n.lungcancer_drugguide-section {\n  margin-bottom: 32px;\n}\n.lungcancer_drugguide-section-title {\n  font-size: 1.32em;\n  font-weight: bold;\n  margin-bottom: 12px;\n  padding: 13px 14px;\n  border-radius: 6px;\n  letter-spacing: 0.01em;\n  line-height: 1.25em;\n  position: relative;\n}\n.lungcancer_drugguide-bg1 { background: linear-gradient(90deg, #f3ebfc 0%, #e0f3ff 95%); }\n.lungcancer_drugguide-bg2 { background: linear-gradient(90deg, #e5f8ef 0%, #fdf4ec 95%); }\n.lungcancer_drugguide-bg3 { background: linear-gradient(90deg, #feeee4 0%, #e9f6fc 95%); }\n.lungcancer_drugguide-bg4 { background: linear-gradient(90deg, #f7f7ff 0%, #e5f1fa 90%); }\n.lungcancer_drugguide-bg5 { background: linear-gradient(90deg, #f7f7ff 0%, #fffce0 100%); }\n.lungcancer_drugguide-bg6 { background: linear-gradient(90deg, #e4fafd 0%, #efe7f3 95%); }\n.lungcancer_drugguide-bg7 { background: linear-gradient(90deg, #fffbe3 0%, #eaf3f8 100%); }\n.lungcancer_drugguide-bg8 { background: linear-gradient(90deg, #fdf6ed 0%, #e8f8f1 100%); }\n.lungcancer_drugguide-bg9 { background: linear-gradient(90deg, #edf6fd 0%, #fbeded 95%); }\n.lungcancer_drugguide-bg10 { background: linear-gradient(90deg, #e7f4ea 0%, #f3edf7 95%); }\n.lungcancer_drugguide-bgref { background: linear-gradient(90deg,#faf3e4 0%,#f4fbfa 95%);}\n.lungcancer_drugguide-section-content ul {\n  margin: 8px 0 8px 0;\n  padding-left: 20px;\n}\n.lungcancer_drugguide-section-content li {\n  margin-bottom: 8px;\n  color: #2f435c;\n}\n.lungcancer_drugguide-section-content strong {\n  color: #187d8b;\n}\n.lungcancer_drugguide-tip {\n  border-left: 5px solid #64b083;\n  background: #e5faef;\n  color: #317257;\n  padding: 10px 16px;\n  border-radius: 6px;\n  margin: 18px 0 10px 0;\n  font-size: 1.04em;\n}\n.lungcancer_drugguide-case {\n  border-left: 5px solid #567eac;\n  background: #e7f3fa;\n  color: #355071;\n  padding: 10px 16px;\n  border-radius: 6px;\n  margin: 18px 0 10px 0;\n  font-size: 1.04em;\n}\n.lungcancer_drugguide-exp {\n  display: block;\n  margin-top: 14px;\n  color: #9b5c2d;\n  font-size: 1.04em;\n  border-left: 4px solid #f2c095;\n  background: #fff5e7;\n  padding: 7px 16px;\n  border-radius: 5px;\n}\n.lungcancer_drugguide-ref {\n  margin-top: 30px;\n  background: #faf9fa;\n  border-radius: 7px;\n  padding: 19px 17px 21px 17px;\n  color: #34435b;\n  box-shadow: 0 0 0 1px #f2ede6;\n}\n.lungcancer_drugguide-ref ol {\n  margin: 8px 0 0 22px ;\n  padding: 0 0 0 2px;\n}\n.lungcancer_drugguide-ref li {\n  margin: 0 0 10px 0;\n  font-size: 15.4px;\n  color: #354367;\n}\n.lungcancer_drugguide-emoji {\n  font-size: 1.13em;\n  vertical-align: middle;\n  margin-left: 2px;\n}\n\n@media (max-width: 600px) {\n  .lungcancer_drugguide-content {padding: 4vw 2vw; font-size: 15px;}\n  .lungcancer_drugguide-title {font-size: 1.16em;}\n  .lungcancer_drugguide-section-title{font-size: 1em;}\n}\n\u003C/style>\n\n","\u003Cdiv class=\"lungcancer_drugguide-content\">\n  \u003Ch1 id=\"material_title\" class=\"lungcancer_drugguide-tit",517,"2025-08-22 16:17:19","晚期肺癌, 静脉化疗, 免疫治疗, 药品安全, 用药指南","了解如何安全、有效使用静脉化疗和免疫治疗药物，掌握用药细节和注意事项，确保治疗效果与安全，尤其适合晚期肺癌患者和家属。","2025-08-26 23:08:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]